Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,279,479
+$726,896 QoQ
Shares Held
135,826
+100.1% QoQ
Ownership
0.082%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 263 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Derivatives in NVAX
reported options exposure · as of Jun 30, 2025CallValue
$6,290,550
CallShares
998,500
PutValue
$7,982,730
PutShares
1,267,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,528,481 across 417 Biotechnology names. NVAX ranks #123 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in NVAX
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,279,479 | 135,826 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $552,583 | 67,885 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $1,119,208 | 166,549 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,854,405 | 329,228 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,199,351 | 666,564 | Shares | Defined | 2025-08-14 | |
| 2025-06-30 | $6,290,550 | 998,500 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $7,982,730 | 1,267,100 | Put | Defined | 2025-08-14 | |
| 2025-03-31 | $1,071,277 | 167,126 | Shares | Defined | 2025-05-13 | |
| 2025-03-31 | $8,122,111 | 1,267,100 | Put | Defined | 2025-05-13 | |
| 2025-03-31 | $11,443,132 | 1,785,200 | Call | Defined | 2025-05-13 | |
| 2024-12-31 | $1,011,792 | 125,845 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,210,762 | 95,864 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $740,368 | 58,481 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $474,654 | 99,300 | Call | Defined | 2024-05-10 | |
| 2024-03-31 | $206,242 | 43,147 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $156,348 | 32,573 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $1,553,954 | 214,635 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,019,063 | 271,745 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,341,418 | 193,567 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $158,373 | 15,406 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $305,703 | 16,797 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $514,300 | 10,000 | Put | Defined | 2022-08-12 | |
| 2022-06-30 | $742,441 | 14,436 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,683,067 | 36,430 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,402,642 | 58,731 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $11,018,110 | 53,148 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $16,490,115 | 77,670 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $16,422,694 | 90,578 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $11,396,207 | 102,199 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $16,546,019 | 152,709 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $12,911,247 | 154,904 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $332,451 | 24,481 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||